| Inhibitors of Factor VIII in Hemophilia REPLY KR Viel, CK Kasper, TE Howard NEW ENGLAND JOURNAL OF MEDICINE 361 (3), 310-310, 2009 | 252* | 2009 |
| Inhibitors of factor VIII in black patients with hemophilia KR Viel, A Ameri, TC Abshire, RV Iyer, RG Watts, C Lutcher, C Channell, ... New England Journal of Medicine 360 (16), 1618-1627, 2009 | 252 | 2009 |
| Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention R Jabara, RR Gadesam, LK Pendyala, WD Knopf, N Chronos, JP Chen, ... The American journal of cardiology 103 (12), 1657-1662, 2009 | 131 | 2009 |
| A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels KR Viel, DK Machiah, DM Warren, M Khachidze, A Buil, K Fernstrom, ... Blood 109 (9), 3713-3724, 2007 | 123 | 2007 |
| Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A GS Pandey, C Yanover, LM Miller-Jenkins, S Garfield, SA Cole, JE Curran, ... Nature medicine 19 (10), 1318-1324, 2013 | 68 | 2013 |
| Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A GS Pandey, C Yanover, LM Miller-Jenkins, S Garfield, SA Cole, JE Curran, ... Nature medicine 19 (10), 1318-1324, 2013 | 63 | 2013 |
| Comparison of the thrombogenicity of stainless steel and tantalum coronary stents NA Scott, KA Robinson, GL Nunes, CN Thomas, K Viel, SB King III, ... American heart journal 129 (5), 866-872, 1995 | 60 | 1995 |
| Genetic determinants of normal variation in coagulation factor (F) IX levels: genome‐wide scan and examination of the FIX structural gene M Khachidze, A Buil, KR Viel, S Porter, D Warren, DK Machiah, JM Soria, ... Journal of Thrombosis and Haemostasis 4 (7), 1537-1545, 2006 | 27 | 2006 |
| PATH (Personalized Alternative Therapies for Hemophilia) Study Investigators. Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the … GS Pandey, C Yanover, LM Miller-Jenkins, S Garfield, SA Cole, JE Curran, ... Nat Med 19 (10), 1318-1324, 2013 | 19 | 2013 |
| Haemophilia management: time to get personal? TE Howard, C Yanover, J Mahlangu, A Krause, KR Viel, CK Kasper, ... Haemophilia 17 (5), 721-728, 2011 | 16 | 2011 |
| African-Americans Express Multiple Haplotypic Forms of the Wildtype Factor VIII (FVIII) Protein: A Possible Role for Pharmacogenetics in FVIII Inhibitor Development?. T Howard, DM Machiah, TT Tran, KR Viel, C Channell, JM Soria, A Ameri, ... ASH Annual Meeting Abstracts 104 (11), 384, 2004 | 12 | 2004 |
| A common SNP in the factor VIII (f-VIII) gene encodes a conservative aspartate to glutamate substitution (Asp1241Glu) in the B-domain that influences f-VIII activity levels. DK Machiah, K Viel, L Almasy, JM Soria, S Porter, JC Souto, J Blangero, ... Blood 102 (11), 55A-55A, 2003 | 12 | 2003 |
| Observations regarding the immunogenicity of BDD‐rFVIII derived from a mechanistic personalized medicine perspective ZE Sauna, A Ameri, B Kim, C Yanover, KR Viel, R Rajalingam, SA Cole, ... Journal of Thrombosis and Haemostasis 10 (9), 1961-1965, 2012 | 9 | 2012 |
| A comparison of discrete versus continuous environment in a variance components-based linkage analysis of the COGA data KR Viel, DM Warren, A Buil, TD Dyer, TE Howard, L Almasy BMC genetics 6 (Suppl 1), S57, 2005 | 5 | 2005 |
| Allelically mismatched replacement therapy due to common African-restricted haplotypes of the factor (F) VIII protein may underlie the increased incidence of FVIII inhibitors … TE Howard, KR Viel, KM Fernstrom, S Deshpande, A Ameri, MS Ali, ... ASH Annual Meeting Abstracts 108 (11), 765, 2006 | 4 | 2006 |
| The Pharmacogenetics and Inhibitor Risk (PIR) Study: establishing the spectrum of factor (F) VIII gene (F8) mutations in African-American hemophilia A patients. TE Howard, DK Machiah, KR Viel, C Channel, A Ameri, RV Iyer, RG Watts, ... ASH Annual Meeting Abstracts 106 (11), 3207, 2005 | 4 | 2005 |
| A linkage analysis of cigarette and alcohol consumption in an unselected Mexican American population K Viel, J Charlesworth, E Tejero, T Dyer, S Cole, K Haack, J MacCluer, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 147 …, 2008 | 3 | 2008 |
| Dissection of heterogeneous phenotypes for quantitative trait mapping H Bickeböller, JN Bailey, GJ Papanicolaou, A Rosenberger, KR Viel Genetic epidemiology 29 (S1), S41-S47, 2005 | 3 | 2005 |
| Coordinate expression of elevated prothrombin and factor X levels; a potential novel mechanism of thrombophilia TE Howard, K Viel, C Channell, A Duncan THROMBOSIS AND HAEMOSTASIS, 542-542, 1999 | 3 | 1999 |
| A Novel Biomarker for Inhibitor Risk Prediction-the HLA-II Bound and Unbound Components of FVIII Derived Peptides-Reveals a Protective Influence for N-Linked Glycosylation KR Viel, M Hofmann, S Zollner, BW Luu, R Raja, JS Powell, ... Blood 126 (23), 2292-2292, 2015 | 2 | 2015 |
